Use of tetrahydrocannabinol and/or cannabidiol for the treatment of inflammatory bowel disease
P Robson, G Guy, R Pertwee… - US Patent App. 12/667,561, 2010 - Google Patents
The present invention relates to the use of a substantially pure tetrahydrocannabinol (THC)
or a THC containing extract in which THC is a primary cannabinoid, in the manufacture of a
medicament for use in the treatment of an inflammatory bowel disease. A further
embodiment of the invention relates to the use of a substantially pure cannabidiol (CBD) or a
CBD containing extract in which CBD is a primary cannabinoid, in the manufacture of a
medicament for use in the treatment of an inflammatory bowel disease. Additionally the …
or a THC containing extract in which THC is a primary cannabinoid, in the manufacture of a
medicament for use in the treatment of an inflammatory bowel disease. A further
embodiment of the invention relates to the use of a substantially pure cannabidiol (CBD) or a
CBD containing extract in which CBD is a primary cannabinoid, in the manufacture of a
medicament for use in the treatment of an inflammatory bowel disease. Additionally the …
